| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |